Advanced targeted nanomedicine.

Targeted drug delivery has been the major topic in drug formulation and delivery. As nanomedicine emerges to create nano scale therapeutics and diagnostics, it is still essential to embed targeting capability to these novel systems to make them useful. Here we discuss various targeting approaches for delivery of therapeutic and diagnostic nano materials in view of search for more universal methods to target diseased tissues. Many diseases are accompanied with hypoxia and acidosis. Coating nanoparticles with pH Low Insertion Peptides (pHLIPs) increases efficiency of targeting acidic diseased tissues. It has been showing promising results to create future nanotheranostics for cancer and other diseases which are dominating in the present world.

[1]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[2]  M. Dellian,et al.  Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time , 2004, Clinical Cancer Research.

[3]  Ick Chan Kwon,et al.  Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. , 2014, Biomaterials.

[4]  H. Karanth,et al.  pH‐Sensitive liposomes‐principle and application in cancer therapy , 2007, The Journal of pharmacy and pharmacology.

[5]  D. Cliffel,et al.  In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[6]  I. Toth,et al.  Cellular transport pathways of polymer coated gold nanoparticles. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[7]  A. Harris,et al.  Targeting the hypoxia-inducible factor (HIF) pathway in cancer , 2009, Expert Reviews in Molecular Medicine.

[8]  L. Feinendegen,et al.  Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth. , 1981, Cancer research.

[9]  L. Boros,et al.  Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress , 2013, Cancer & metabolism.

[10]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. Dobson,et al.  Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.

[12]  Y. Magata,et al.  X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer , 2010, Nanotechnology.

[13]  D. Engelman,et al.  Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer , 2014, Proceedings of the National Academy of Sciences.

[14]  Yoon Yeo,et al.  Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. , 2009, Molecular pharmaceutics.

[15]  F. Szoka,et al.  Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture , 1990, Pharmaceutical Research.

[16]  D. Engelman,et al.  Roles of carboxyl groups in the transmembrane insertion of peptides. , 2011, Journal of molecular biology.

[17]  D. Engelman,et al.  Spontaneous , pH-Dependent Membrane Insertion of a Transbilayer R-Helix † , 1997 .

[18]  Xiaobing Zhang,et al.  A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery. , 2013, Angewandte Chemie.

[19]  V. Torchilin,et al.  ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[21]  D. Engelman,et al.  Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide. , 2011, Biochemistry.

[22]  David S. Jones,et al.  Triggered drug delivery from biomaterials , 2010, Expert opinion on drug delivery.

[23]  Yana K Reshetnyak,et al.  A novel technology for the imaging of acidic prostate tumors by positron emission tomography. , 2009, Cancer research.

[24]  Dihua Yu,et al.  Breast cancer chemosensitivity , 2007 .

[25]  Brenda Baggett,et al.  Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. , 2003, Biochemical pharmacology.

[26]  K. Widder,et al.  Magnetic guidance of drug‐carrying microspheres , 1978 .

[27]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[28]  Hirofumi Takeuchi,et al.  Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  G. Robertson,et al.  Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. , 2008, Cancer research.

[30]  Va Carroll,et al.  Role of HIF-1α versus HIF-2α in the regulation of HIF target genes: Implications for targeting the HIF pathway. , 2006 .

[31]  D. Engelman,et al.  Measuring Tumor Aggressiveness and Targeting Metastatic Lesions with Fluorescent pHLIP , 2011, Molecular Imaging and Biology.

[32]  D. Engelman,et al.  pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path , 2010, Proceedings of the National Academy of Sciences.

[33]  Håkan Wallin,et al.  Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[34]  Y. Reshetnyak,et al.  pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[35]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[36]  Kazuo Maruyama,et al.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.

[37]  F. Szoka,et al.  pH-dependent bilayer destabilization by an amphipathic peptide. , 1987, Biochemistry.

[38]  A. Moshnikova,et al.  Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment , 2014, Scientific Reports.

[39]  C. Schiffer.  Seminars in oncology , 2001 .

[40]  Robert Langer,et al.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.

[41]  G. Melillo,et al.  Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia , 2012, Nature Reviews Clinical Oncology.

[42]  S. Bartling,et al.  Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. , 2007, Biomaterials.

[43]  Raghuraman Kannan,et al.  Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography. , 2010, Academic radiology.

[44]  Sangjin Park,et al.  Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007 .

[45]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[46]  Thermosensitive polymeric hydrogels as drug delivery systems. , 2012 .

[47]  Vladimir P Torchilin,et al.  Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.

[48]  Tuo Wei,et al.  Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. , 2012, ACS nano.

[49]  Liang Han,et al.  pH‐Controlled Delivery of Nanoparticles into Tumor Cells , 2013, Advanced healthcare materials.

[50]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[51]  D. Engelman,et al.  pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation , 2010, Proceedings of the National Academy of Sciences.

[52]  James Nyagilo,et al.  Gold nanotags for combined multi-colored Raman spectroscopy and x-ray computed tomography , 2010, Nanotechnology.

[53]  D. Engelman,et al.  Modulation of the pHLIP transmembrane helix insertion pathway. , 2012, Biophysical journal.

[54]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[55]  T. Shimamoto,et al.  Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia. , 1991, The Journal of pharmacology and experimental therapeutics.

[56]  F. Rinaldi,et al.  Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. , 2011, Colloids and surfaces. B, Biointerfaces.

[57]  O. Farokhzad,et al.  Nanoparticles for Targeted and Temporally Controlled Drug Delivery , 2012 .

[58]  G. Tuszynski,et al.  The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis , 2009, Pathology Oncology Research.

[59]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[60]  Valerie A Longo,et al.  (18)F-labeled-bioorthogonal liposomes for in vivo targeting. , 2013, Bioconjugate chemistry.

[61]  R. J. Lee,et al.  Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.

[62]  Yana K Reshetnyak,et al.  Family of pH (low) insertion peptides for tumor targeting , 2013, Proceedings of the National Academy of Sciences.

[63]  S. Cheng,et al.  Gold-doxorubicin nanoconjugates for overcoming multidrug resistance. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[64]  A. Moshnikova,et al.  Antiproliferative E ff ect of pHLIP-Amanitin , 2013 .

[65]  S. Hladky,et al.  Ion transfer across lipid membranes in the presence of gramicidin A. I. Studies of the unit conductance channel. , 1972, Biochimica et biophysica acta.

[66]  D. Engelman,et al.  Targeting diseased tissues by pHLIP insertion at low cell surface pH , 2013, Front. Physiol..

[67]  F. Marshall,et al.  In vivo molecular and cellular imaging with quantum dots. , 2005, Current opinion in biotechnology.

[68]  D. Pal,et al.  Bhasma : The ancient Indian nanomedicine , 2014, Journal of advanced pharmaceutical technology & research.

[69]  V. Postnov,et al.  Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity , 2010, International journal of nanomedicine.

[70]  Diane Dalecki,et al.  Mechanical bioeffects of ultrasound. , 2004, Annual review of biomedical engineering.

[71]  Udo Greiser,et al.  Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. , 2003, Cancer research.

[72]  Napoleone Ferrara,et al.  Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.

[73]  D. Engelman,et al.  Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[75]  Madhusudhan R. Papasani,et al.  Gold-peptide nanoconjugate cellular uptake is modulated by serum proteins. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[76]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[77]  Alan Wayne Jones,et al.  Early drug discovery and the rise of pharmaceutical chemistry. , 2011, Drug testing and analysis.

[78]  E. Martínez,et al.  Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications , 2010, Expert opinion on drug delivery.

[79]  Menachem Motiei,et al.  Nanoparticles as computed tomography contrast agents: current status and future perspectives. , 2012, Nanomedicine.

[80]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[81]  Jochen Ringe,et al.  Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. , 2012, Biomaterials.

[82]  Paula T Hammond,et al.  Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia. , 2011, ACS nano.

[83]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[84]  J. Leroux,et al.  Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid Tumors , 2006, Pharmaceutical Research.

[85]  Biofunctionalized targeted nanoparticles for therapeutic applications , 2008 .

[86]  D. Engelman,et al.  RESEARCH ARTICLE In Vivo pH Imaging with 99m Tc-pHLIP , 2012 .

[87]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[88]  S. Ansari,et al.  Influence of nanotechnology on herbal drugs: A Review , 2012, Journal of advanced pharmaceutical technology & research.

[89]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[90]  E. Unger,et al.  Local drug and gene delivery through microbubbles. , 2001, Progress in cardiovascular diseases.

[91]  Sadik Esener,et al.  Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment , 2013, Drug design, development and therapy.

[92]  P. Low,et al.  The Effects of pH and Intraliposomal Buffer Strength on the Rate of Liposome Content Release and Intracellular Drug Delivery , 1998, Bioscience reports.

[93]  Robert Langer,et al.  Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.

[94]  R. Freeman,et al.  Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. , 2005, Current drug targets. CNS and neurological disorders.

[95]  Jiun-Jie Wang,et al.  Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs , 2010 .

[96]  Y. Ogawa,et al.  Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. , 1990, Radiation research.

[97]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  D. Engelman,et al.  Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix. , 1997, Biochemistry.

[99]  Dohyung Lim,et al.  Heparin-coated gold nanoparticles for liver-specific CT imaging. , 2009, Chemistry.

[100]  T. Porter,et al.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[101]  M. Ueno,et al.  Targeting behavior of hepatic artery injected temperature sensitive liposomal adriamycin on tumor-bearing rats. , 1990, Selective Cancer Therapeutics.

[102]  S. Mousa.  Angiogenesis Inhibitors and Stimulators: Potential Therapeutic Implications , 2000 .

[103]  G. Nagy,et al.  Physiological and pathological angiogenesis in the endocrine system , 2003, Microscopy research and technique.

[104]  F. Gu,et al.  Biofunctionalized targeted nanoparticles for therapeutic applications , 2008, Expert opinion on biological therapy.

[105]  A. Novell,et al.  Focused ultrasound mediated drug delivery from temperature-sensitive liposomes: in-vitro characterization and validation , 2013, Physics in medicine and biology.

[106]  S. Curley,et al.  Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[107]  D. Kaufman.  Challenges in the treatment of bladder cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[108]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[109]  Ward Brullot,et al.  Magnetic-plasmonic nanoparticles for the life sciences: calculated optical properties of hybrid structures. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[110]  J. Folkman,et al.  Fighting cancer by attacking its blood supply. , 1996, Scientific American.

[111]  M Geso,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.

[112]  R. Jain.  Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. , 2002, Seminars in oncology.

[113]  Y. Reshetnyak,et al.  pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis , 2013, Scientific Reports.

[114]  G. Hortobagyi,et al.  Overview of resistance to systemic therapy in patients with breast cancer. , 2007, Advances in experimental medicine and biology.

[115]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[116]  Kenneth A. Barbee,et al.  Targeted drug delivery to magnetic implants for therapeutic applications , 2005 .

[117]  T. Murakami,et al.  Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. , 2000, International journal of oncology.

[118]  Scott D Fitzpatrick,et al.  Temperature-sensitive polymers for drug delivery , 2012, Expert review of medical devices.

[119]  D. Engelman,et al.  pHLIP peptide targets nanogold particles to tumors , 2012, Proceedings of the National Academy of Sciences.

[120]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[121]  W. Pitt,et al.  Ultrasonic drug delivery – a general review , 2004, Expert opinion on drug delivery.

[122]  J. Lindner.  Evolving applications for contrast ultrasound. , 2002, The American journal of cardiology.

[123]  J. Pouysségur,et al.  Hypoxia and cancer , 2007, Journal of Molecular Medicine.

[124]  C. Gong,et al.  Thermosensitive polymeric hydrogels as drug delivery systems. , 2012, Current medicinal chemistry.

[125]  David J. Robertson,et al.  Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[126]  A. Ziegler.  Antibody Targeting of Liposomes : Cell Specificity Obtained by Conjugation of F ( ab ' ) 2 to Vesicle Surface , 2011 .

[127]  R L Magin,et al.  Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. , 1979, Science.

[128]  R. Gillies,et al.  Drug resistance and cellular adaptation to tumor acidic pH microenvironment. , 2011, Molecular pharmaceutics.

[129]  R Blumenthal,et al.  Design of liposomes for enhanced local release of drugs by hyperthermia. , 1978, Science.

[130]  J. Pouysségur,et al.  Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer , 2009, Journal of cellular and molecular medicine.

[131]  D. Panagiotakos,et al.  Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  Feng Zan,et al.  Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[133]  J. R. Tacker,et al.  Delivery of antitumor drug to bladder cancer by use of phase transition liposomes and hyperthermia. , 1982, The Journal of urology.

[134]  Esben A. Nilssen,et al.  Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice , 2011, Journal of drug targeting.

[135]  Samuel Woojoo Jun,et al.  Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. , 2011, Journal of the American Chemical Society.

[136]  Khaled Greish,et al.  Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines , 2007, Journal of drug targeting.

[137]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[138]  D. J. Lewis,et al.  pH-controlled delivery of luminescent europium coated nanoparticles into platelets , 2012, Proceedings of the National Academy of Sciences.

[139]  Guankui Wang,et al.  KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[140]  Cindy A. Wanger-Baumann,et al.  Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. , 2012, Bioconjugate chemistry.

[141]  H. Takeuchi,et al.  pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[142]  D. Engelman,et al.  pHLIP-mediated translocation of membrane-impermeable molecules into cells. , 2009, Chemistry & biology.

[143]  Robert J. Gillies,et al.  A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.

[144]  A. Moshnikova,et al.  Antiproliferative effect of pHLIP-amanitin. , 2013, Biochemistry.

[145]  Rodney A. Hill,et al.  Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[146]  D. Engelman,et al.  pH (low) insertion peptide (pHLIP) targets ischemic myocardium , 2012, Proceedings of the National Academy of Sciences.

[147]  K. Sugimachi,et al.  Selective treatment of metastatic lymph nodes with combination of local hyperthermia and temperature-sensitive liposomes containing bleomycin. , 1987, Cancer treatment reports.

[148]  C. Jha,et al.  Physicochemical characterization of Ayurvedic bhasma (Swarna makshika bhasma): An approach to standardization , 2010, International journal of Ayurveda research.

[149]  D. Engelman,et al.  A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. , 2007, Biophysical journal.

[150]  J. Pedraz,et al.  Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research , 2012, Clinical and Translational Oncology.

[151]  Thomas F. George,et al.  Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[152]  Jan Grimm,et al.  An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles , 2006, Nature materials.

[153]  J. Weidner.  Drug delivery. , 2001, Drug discovery today.

[154]  P. A. Dijkmansa,et al.  Microbubbles and ultrasound : from diagnosis to therapy , 2004 .

[155]  Antony K. Chen,et al.  Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.

[156]  M. Kiani,et al.  Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue , 2008, Expert opinion on drug delivery.

[157]  D. Sugarbaker,et al.  Patterns of failure after trimodality therapy for malignant pleural mesothelioma. , 1997, The Annals of thoracic surgery.

[158]  S. Seaman,et al.  Genes that distinguish physiological and pathological angiogenesis. , 2007, Cancer cell.

[159]  K. Widder,et al.  Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.